Northwire Canada EditionSunday, October 18, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0%

Healthcare

Page 104
  1. Nov 12, 2025 · 16:05 · GLAS

    Glass House Brands Reports Third Quarter 2025 Financial Results

    Glass House Brands Reports Third Quarter 2025 Financial Results

    01
  2. Nov 12, 2025 · 16:02 · NRX

    NurExone Secures over C$3.18 Million Through Accelerated Warrant Exercises

    NurExone Secures over C$3.18 Million Through Accelerated Warrant Exercises

    02
  3. Nov 12, 2025 · 09:28 · PCRX

    PharmaCorp Announces Closing of C$23 Million Bought Deal Public Offering

    PharmaCorp Announces Closing of C$23 Million Bought Deal Public Offering

    03
  4. Nov 12, 2025 · 08:30 · PRN

    Profound Medical Announces Strategic Distribution Agreement with Getz Healthcare to Bring TULSA-PRO(TM) to Australia and New Zealand

    Profound Medical Announces Strategic Distribution Agreement with Getz Healthcare to Bring TULSA-PRO(TM) to Australia and New Zealand

    04
  5. Nov 12, 2025 · 07:00 · MBX

    Microbix Partners with SEKISUI Diagnostics to Support COVID/Flu Tests

    Microbix Partners with SEKISUI Diagnostics to Support COVID/Flu Tests

    05
  6. Nov 11, 2025 · 18:03 · PRN

    Profound signs exclusive Saudi Arabia distribution deal

    Profound signs exclusive Saudi Arabia distribution deal

    06
  7. Nov 11, 2025 · 17:15 · CSCI

    COSCIENS Biopharma Inc. Reports Third Quarter 2025 Financial Results and Provides Strategic Initiatives Update

    COSCIENS Biopharma Inc. Reports Third Quarter 2025 Financial Results and Provides Strategic Initiatives Update

    07
  8. Nov 11, 2025 · 17:00 · EXE

    Extendicare Announces 2025 Third Quarter Results

    Extendicare Announces 2025 Third Quarter Results

    08
  9. Nov 11, 2025 · 16:15 · PRN

    Profound Medical Inks Exclusive Distribution Agreement for TULSA-PRO(TM) and Sonalleve(TM) with Al Faisaliah Medical Systems in Saudi Arabia

    Profound Medical Inks Exclusive Distribution Agreement for TULSA-PRO(TM) and Sonalleve(TM) with Al Faisaliah Medical Systems in Saudi Arabia

    09
  10. Nov 11, 2025 · 14:41 · VVTM

    VVT Med Signs $3.7 Million Distribution Agreement in India, Achieves European Sales Milestone and Announces Proposed Debt Settlement

    VVT Med Signs $3.7 Million Distribution Agreement in India, Achieves European Sales Milestone and Announces Proposed Debt Settlement

    10
  11. Nov 10, 2025 · 23:37 · EKG

    CardioComm Receives TSX Venture Exchange Approval for Announced Loan Facility

    CardioComm Receives TSX Venture Exchange Approval for Announced Loan Facility

    11
  12. Nov 10, 2025 · 22:31 · JUMP

    LevelJump Announces 2025 Third Quarter Results

    LevelJump Announces 2025 Third Quarter Results

    12
  13. Nov 10, 2025 · 18:26 · TLT

    Theralase Technologies loses $3.43-million in Q3

    Theralase Technologies loses $3.43-million in Q3

    13
  14. Nov 10, 2025 · 16:36 · ADK

    DIAGNOS Announces $2.0 Million Brokered Private Placement Led by Centurion One Capital

    DIAGNOS Announces $2.0 Million Brokered Private Placement Led by Centurion One Capital

    14
← Newer Older →